Erectile Dysfunction in Hypertension and Cardiovascular Disease A Guide for Clinicians /

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Viigimaa, Margus (Επιμελητής έκδοσης), Vlachopoulos, Charalambos (Επιμελητής έκδοσης), Doumas, Michael (Επιμελητής έκδοσης)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2015.
• Θέματα: Medicine.; Cardiology.; Nephrology.; Urology.; Medicine & Public Health.

 This concise guide to the often overlooked association between erectile dysfunction and hypertension/cardiovascular disease covers a wide range of aspects of importance to the clinician. It examines the impact of antihypertensive drug therapy on erectile function and explains how the management of erectile dysfunction in hypertensive patients depends on a variety of factors. Different treatment approaches are described, including lifestyle modification, PDE-5 inhibitors and other novel agents, and behavioral therapy, and helpful therapeutic algorithms are presented. A further focus of the book is the potential role of erectile dysfunction as an early diagnostic indicator of asymptomatic coronary artery disease and a prognostic marker for cardiovascular events. In addition, key background information is supplied on epidemiology and pathophysiology, and the significance of erectile dysfunction in different patient groups, such as the elderly and those with chronic kidney disease, is examined. Erectile dysfunction is a major public health problem affecting more than ten percent of the general male population and is now considered to be predominantly of vascular origin. This book will be informative and of practical value for all practitioners responsible for caring for the very many patients who experience erectile dysfunction in the setting of hypertension and cardiovascular disease. 

 1 Definition and assessment of erectile dysfunction -- 2 Epidemiology of erectile dysfunction in hypertension -- 3 Pathophysiology of erectile dysfunction -- 4 Erectile dysfunction and testosterone -- 5 The role of the renin-angiotensin system in ED: present and future -- 6 Erectile dysfunction and target organ damage -- 7 Erectile dysfunction in CAD and heart failure -- 8 Erectile dysfunction as an “early diagnostic window” for asymptomatic CAD -- 9 ED and prognostic role for CV events -- 10 Erectile dysfunction in chronic kidney disease -- 11 Erectile dysfunction and sleep-apnea in hypertensive patients -- 12 Diabetes mellitus and ED -- 13 Dyslipidemia and ED -- 14 Endocrine disorders and erectile dysfunction -- 15 Metabolic syndrome and ED -- 16 Erectile dysfunction in the elderly -- 17 Lifestyle modification in erectile dysfunction and hypertension -- 18 Antihypertensive drug therapy and erectile dysfunction -- 19 PDE-5 inhibitors for the treatment of erectile dysfunction in hypertensives -- 20 Management of erectile dysfunction beyond PDE-5 inhibitors -- 21 Behavioral therapy for the treatment of erectile dysfunction -- 22 Basic principles of the Princeton Recommendations -- 23 Sexual counselling in patients with ED -- 24 Management of erectile dysfunction: Therapeutic algorithm.